Animalcare Group plc (LON: ANCR)

Market Cap	137.65M
Revenue (ttm)	74.35M
Net Income (ttm)	1.20M
Shares Out	60.11M
EPS (ttm)	0.02
PE Ratio	114.50
Forward PE	n/a
Dividend	0.05 (2.18%)
Ex-Dividend Date	Jun 20, 2024

Volume	7,464
Open	232.00
Previous Close	227.00
Day's Range	225.01 - 234.00
52-Week Range	160.00 - 240.00
Beta	0.48
Analysts	n/a
Price Target	293.50 (+28.17%)
Earnings Date	Apr 9, 2024

About Animalcare Group

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets. The company also offers microchipping and other associated services. It operates in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, other European countries, Asia, the Middle East, Africa, and internationally. Animalcare Group plc is based in York, the United Kingdom.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Jennifer Ann Julia Winter B.Sc.
• Country: United Kingdom
• Stock Exchange: London Stock Exchange
• Ticker Symbol: ANCR

Financial Performance

In 2023, ANCR's revenue was 74.35 million, an increase of 3.82% compared to the previous year's 71.62 million. Earnings were 1.20 million, a decrease of -38.98%.